Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

Pre-Open Movers: Nielsen Climbs 20%, AppLivin Makes Offer for Unity

Stock Markets Aug 09, 2022 08:54
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
MRSN
+2.80%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BIRD
+10.37%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TASK
+7.66%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
APP
+4.86%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
GDRX
+1.39%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
U
+5.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

BBQ Holdings Inc (NASDAQ:BBQ) +46%; entered into a definitive merger agreement under which MTY would acquire all of the issued and outstanding common shares of BBQ Holdings for cash consideration of US$17.25 per BBQ Holdings share representing total transaction value of approximately US$200 million (C$257 million), including BBQ Holdings’ net debt.

GoodRx Holdings Inc (NASDAQ:GDRX+28%; Revenue for the quarter came in at $191.8 million versus the consensus estimate of $185.36 million.

Helbiz (NASDAQ:HLBZ) climbs +27%.

Nielsen Holdings (NYSE:NLSN) +21%; announced that the court meeting and the special meeting of its shareholders due to be held today have been postponed. The purpose of the Meetings was to consider and vote on proposals to give effect to the transaction contemplated by the previously announced definitive agreement for the Company to be acquired by a private equity consortium composed of Evergreen Coast Capital Corp., an affiliate of Elliott Investment Management L.P., and Brookfield Business Partners L.P. together with other institutional partners (collectively "Brookfield").

Mersana Therapeutics (NASDAQ:MRSN) +14%; announced a global collaboration that provides GSK plc (LON:GSK) an exclusive option to co-develop and commercialize XMT-2056, an Immunosynthen ADC that targets a novel epitope of HER2. XMT-2056 is designed to activate the innate immune system through STING signaling in both tumor-resident immune cells and in tumor cells.

Lemonade (NYSE:LMND+11%; reported Q2 EPS of ($1.10), $0.23 better than the analyst estimate of ($1.33). Revenue for the quarter came in at $50 million versus the consensus estimate of $47.56 million.GUIDANCE: Lemonade sees Q3 2022 revenue of $63-65 million, versus the consensus of $56.98 million. Lemonade sees FY2022 revenue of $236-239 million, versus the consensus of $214.67 million.

Aikido Pharma (NASDAQ:AIKI+3%; Shalom Auerbach, a significant stockholdPharma Incer of AIkido beneficially owning approximately 3.8% of its common stock, today announced that he has sent a letter proposing to acquire the Company for $8.00 per share in cash.

Unity Software Inc (NYSE:U) +7%; AppLovin (NASDAQ:APP) today announced it has submitted a compelling non-binding proposal to the Board of Directors of Unity Software Inc to combine AppLovin, a leader in mobile marketing and monetization, with Unity, an industry-leading platform for creating and operating interactive, real-time 3D (RT3D) content, in a transaction where each outstanding share of Unity common stock would be exchanged for 1.152 shares of AppLovin Class A voting common stock and 0.314 shares of AppLovin Class C non-voting common stock.

CorMedix (NASDAQ:CRMD) -60%; today announced updates related to the FDA review of the DefenCath New Drug Application (NDA) as well as other manufacturing and commercial updates. A second Complete Response Letter (CRL) was received from the FDA stating that the DefenCath NDA cannot be approved until deficiencies recently conveyed to the contract manufacturing organization (CMO) and the supplier of the active pharmaceutical ingredient (API) heparin during inspections are resolved to the satisfaction of FDA.

Novavax (NASDAQ:NVAX) -32%; Novavax reported Q2 EPS of ($6.53), $12.03 worse than the analyst estimate of $5.50. Revenue for the quarter came in at $186 billion versus the consensus estimate of $1.02 billion. GUIDANCE: Novavax sees FY2022 revenue of $2-2.3 billion, versus the consensus of $4.27 billion.

TaskUs Inc (NASDAQ:TASK-16%; reported Q2 EPS of $0.38, $0.05 better than the analyst estimate of $0.33. Revenue for the quarter came in at $246.5 million versus the consensus estimate of $242.11 million. GUIDANCE: TaskUs sees Q3 2022 revenue of $224-226 million, versus the consensus of $244 million. TaskUs sees FY2022 revenue of $930-950 million, versus the consensus of $992 million.

CarGurus (NASDAQ:CARG) -15%; reported Q2 EPS of $0.32, $0.01 better than the analyst estimate of $0.31. Revenue for the quarter came in at $511.2 million versus the consensus estimate of $507.32 million. GUIDANCE: CarGurus sees Q3 EPS of $0.25-$0.28, versus the consensus of $0.33. CarGurus sees Q3 revenue of $460-490 million, versus the consensus of $554.6 million.

3D Systems (NYSE:DDD) -13%; reported Q2 EPS of ($0.07), $0.07 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $140 million versus the consensus estimate of $146.8 million. GUIDANCE: 3D Systems sees 2022 revenue of $530-570 million, versus the consensus of $598 million.

Allbirds Inc (NASDAQ:BIRD) -13%; reported Q2 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $78.2 million versus the consensus estimate of $77.8 million. GUIDANCE: Allbirds sees FY2022 revenue of $305-315 million, versus the consensus of $339.6 million.

Trex (NYSE:TREX-12%; reported Q2 EPS of $0.79, $0.12 better than the analyst estimate of $0.67. Revenue for the quarter came in at $386 million versus the consensus estimate of $381.1 million. GUIDANCE: Trex sees Q3 2022 revenue of $185-195 million, versus the consensus of $354.82 million. Trex sees FY2022 revenue of $1.09-1.11 billion, versus the consensus of $1.38 billion.

Norwegian Cruise Line (NYSE:NCLH) -9%; reported Q2 EPS of ($1.14), $0.26 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.26 billion. Outlook: Total revenue is expected to be $1.5-$1.6 billion in the third quarter of 2022 vs consensus of $1.88 billion)

 
Pre-Open Movers: Nielsen Climbs 20%, AppLivin Makes Offer for Unity
 

Related Articles

Next Slumps on Guidance Cut After Weak Summer
Next Slumps on Guidance Cut After Weak Summer By Investing.com - Sep 29, 2022

By Geoffrey Smith  Investing.com -- Shares in Next (LON:NXT) slumped on Thursday to its lowest in more than two years, as the U.K. fashion chain cut its outlook for the second...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email